Prevalence of cervical myelomalacia in adult patients requiring a cervical magnetic resonance imaging.
Yihua Zhou, Sang D Kim, Katie Vo...
https://pubmed.ncbi.nlm.nih.gov/25423302/Actively Recruiting
Led by Ankara City Hospital Bilkent · Updated on 2026-10-21
400
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are conducting a prospective observational study to find out how common cervical spinal cord signal abnormalities, such as myelomalacia, are among adults who visit a tertiary pain clinic with cervical radicular pain. The study will enroll 400 consecutive patients and aims to explore clinical signs and MRI findings related to this condition. The research also examines treatment choices, clinical and imaging factors influencing those choices, and the link between the Hoffmann sign and spinal cord abnormalities. Participants will undergo routine clinical and neurological exams, including assessment of the Hoffmann sign, and cervical MRI scans as part of their usual care. These MRI scans will be evaluated for spinal canal narrowing, spinal cord compression, signal abnormalities, and myelomalacia. The study does not assign any diagnostic procedures or treatments but observes information collected during regular clinical practice. During the study, clinical exam results and MRI findings will be recorded alongside treatment decisions made by the treating physicians. Researchers will analyze the prevalence of spinal cord abnormalities and related clinical factors at the initial evaluation. The study respects routine medical care without altering clinical decisions. Participation involves data collection during normal visits, with the primary outcome focused on MRI-detected spinal cord signal abnormalities.
CONDITIONS
Cervical Spinal Cord Signal Abnormalities in Patients With Cervical Radicular Pain
Ü
Ülkü Sabuncu, Assoc prof
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ankara City Hospital Bilkent
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At initial clinical evaluation
Participants undergo routine clinical and neurological examinations, including MRI scans as part of their usual care. Findings such as the Hoffmann sign and MRI results are recorded for research purposes without altering treatment decisions.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Yihua Zhou, Sang D Kim, Katie Vo...
https://pubmed.ncbi.nlm.nih.gov/25423302/J A Glaser, J K Curé, K L Bailey...
https://pubmed.ncbi.nlm.nih.gov/11813951/Ankara City Hospital Bilkent
Lead Sponsor